FCF co-organized, along with its companion YAFO Capital, the “ACCESS CHINA Biotech Discussion board” which was held on-line on June 21st & 24th, 2022. ACCESS CHINA Biotech Discussion board...
FCF co-organizes, along with its accomplice YAFO Capital, the “ACCESS CHINA Biotech Discussion board” which will probably be held on-line on June 21st & 24th, 2022. ACCESS CHINA Biotech...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Biotech Enterprise Capital Monitor – USA 04/2022”. The Monitor is a month-to-month printed overview of enterprise...
FCF Life Sciences advises main healthcare firms in Europe on financing transactions (fairness, debt, and licensing) with regional and worldwide traders. Our staff consists of science-driven trade and finance consultants...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Biotech Enterprise Capital Monitor – USA 03/2022”. The Monitor is a month-to-month revealed overview of enterprise...
FCF co-organizes, along with its associate YAFO Capital, the “ACCESS CHINA Biotech Discussion board” which shall be held on-line on April 18th & 19th, 2022. ACCESS CHINA Biotech Discussion...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Biotech Enterprise Capital Monitor – USA 02/2022”. The Monitor is a month-to-month printed overview of enterprise...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Biotech Enterprise Capital Monitor – USA 01/2022”. The Monitor is a month-to-month revealed overview of enterprise...
With a quantity of roughly USD 33.0bn, the general financing for US biotech firms in 2021 but once more surpassed the entire funding of the earlier yr (USD 22.4bn)....
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Biotech Enterprise Capital Monitor – USA 12/2021”. The Monitor is a month-to-month revealed overview of enterprise...